Processing

Please wait...

Settings

Settings

Goto Application

1. WO2007146900 - ANTIHYPERTENSIVE THERAPY METHOD

Publication Number WO/2007/146900
Publication Date 21.12.2007
International Application No. PCT/US2007/070933
International Filing Date 12.06.2007
IPC
A61K 31/422 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
41having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
42Oxazoles
422not condensed and containing further heterocyclic rings
A61K 45/06 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45Medicinal preparations containing active ingredients not provided for in groups A61K31/-A61K41/132
06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
A61P 7/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
7Drugs for disorders of the blood or the extracellular fluid
A61P 9/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9Drugs for disorders of the cardiovascular system
CPC
A61K 31/422
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
41having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
42Oxazoles
422not condensed and containing further heterocyclic rings
A61K 45/06
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
A61P 7/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
7Drugs for disorders of the blood or the extracellular fluid
A61P 9/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9Drugs for disorders of the cardiovascular system
Applicants
  • GILEAD COLORADO, INC. [US]/[US] (AllExceptUS)
  • GORCZYNSKI, Richard, J. [US]/[US] (UsOnly)
Inventors
  • GORCZYNSKI, Richard, J.
Agents
  • FORBES, James, C.
Priority Data
60/813,96615.06.2006US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) ANTIHYPERTENSIVE THERAPY METHOD
(FR) PROCÉDÉ DE TRAITEMENT ANTIHYPERTENSEUR
Abstract
(EN)
Methods and therapeutic combinations are provided for lowering blood pressure in a subject exhibiting resistance to a baseline antihypertensive therapy with one or more drugs, or a subject having diabetes and/or chronic kidney disease. A method of the invention comprises administering, in some embodiments adjunctively with a modified baseline therapy, a compound of formula (I) as defined herein. A therapeutic combination of the invention comprises a compound of formula (I); at least one diuretic; and at least one antihypertensive drug selected from ACE inhibitors, angiotensin II receptor blockers, beta-adrenergic receptor blockers and calcium channel blockers; wherein the at least one diuretic and/or the at least one antihypertensive drug are present at substantially less than a full dose.
(FR)
L'invention concerne des procédés et des combinaisons thérapeutiques destinés à abaisser la pression sanguine chez un sujet qui présente une résistance à un traitement antihypertenseur de base utilisant un ou plusieurs médicaments, ou un sujet atteint de diabète et/ou d'une maladie rénale chronique. Un procédé selon l'invention comprend l'administration d'un composé de formule (I) tel que défini ici, dans certains modes de réalisation conjointement avec un traitement de base modifié. Une combinaison thérapeutique selon l'invention comprend un composé de formule (I); au moins un diurétique; et au moins un antihypertenseur choisi parmi des inhibiteurs de l'ECA, des bloqueurs des récepteurs de l'angiotensine II, des bloqueurs des récepteurs bêta-adrénergiques et des bloqueurs des canaux calciques. Dans cette combinaison, le ou les diurétiques et/ou le ou les médicaments antihypertenseurs sont présents à une dose sensiblement inférieure à une dose complète.
Also published as
Latest bibliographic data on file with the International Bureau